Quantcast
Viewing all articles
Browse latest Browse all 3494

Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025

Metsera, one of the few biotechs to complete an IPO this year, is making its best effort to catch up to the obesity drug giants: Eli Lilly and Novo Nordisk. The startup landed a ...

Viewing all articles
Browse latest Browse all 3494

Trending Articles